Compare BAND & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAND | GRDN |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail-Drug Stores and Proprietary Stores |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | 2017 | 2023 |
| Metric | BAND | GRDN |
|---|---|---|
| Price | $49.19 | $39.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $68.60 | $49.86 |
| AVG Volume (30 Days) | ★ 800.5K | 545.5K |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $204,113,000.00 | ★ $1,448,685,000.00 |
| Revenue This Year | $20.17 | N/A |
| Revenue Next Year | $4.45 | $6.35 |
| P/E Ratio | ★ N/A | $117.77 |
| Revenue Growth | ★ 25.26 | 17.93 |
| 52 Week Low | $12.50 | $25.02 |
| 52 Week High | $79.08 | $48.33 |
| Indicator | BAND | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 40.72 | 40.24 |
| Support Level | $48.15 | $38.49 |
| Resistance Level | $56.74 | $39.62 |
| Average True Range (ATR) | 3.67 | 1.32 |
| MACD | -1.56 | -0.31 |
| Stochastic Oscillator | 23.89 | 7.98 |
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of its revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.